Reneo Pharmaceuticals Inc. (RPHM) NASDAQ

$6.31 -0.57 (-8.29%)

Market Cap: $168.04M

As of 12/01/21 04:00 PM EST. Market closed.

(RPHM)

Reneo Pharmaceuticals Inc. (RPHM) NASDAQ

$6.31 -0.57 (-8.29%)

Market Cap: $168.04M

As of 12/01/21 04:00 PM EST. Market closed.

Reneo is a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). Reneo is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy ... read more

Reneo is a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). Reneo is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes. REN001 has been shown to increase transcription of genes involved in mitochondrial function and increase fatty acid oxidation, and may increase production of new mitochondria. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
18
Address
.
KEY STATS
Open
$6.96
Previous Close
$6.88
Days Range
$6.31 - $6.98
52 week range
$6.10 - $17.18
Volume
24,387
Avg. Volume (30 days)
34,632
Market Cap
$168.04M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
24,423,900
Open
$6.96
Previous Close
$6.88
Days Range
$6.31 - $6.98
52 week range
$6.10 - $17.18
Volume
24,387
Avg. Volume (30 days)
34,632
Market Cap
$168.04M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
24,423,900

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR RENEO PHARMACEUTICALS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Jindal Vineet R. Chief Financial Officer Aug 25, 2021 Buy $7.44 5,000 37,176 5,000 Aug 26, 2021, 05:54 PM
FLESHER GREGORY J. President and CEO Aug 25, 2021 Buy $8.00 8,000 64,000 8,000 Aug 26, 2021, 05:52 PM
Cruse Michael Senior VP-Corporate Operations Aug 25, 2021 Buy $7.45 2,500 18,616 2,500 Aug 26, 2021, 05:51 PM
Muralidhar Bali Director Jul 14, 2021 Buy $8.50 111,736 949,756 2,073,957 Jul 15, 2021, 05:34 PM
Johnson Wendy S. Chief Development Officer Jul 14, 2021 Sale $8.50 111,736 949,756 0 Jul 15, 2021, 05:33 PM
Johnson Wendy S. Chief Development Officer Jul 08, 2021 Option Exercise $1.97 111,736 220,120 111,736 Jul 09, 2021, 06:52 PM
Muralidhar Bali Director Jun 22, 2021 Buy $8.72 14,615 127,487 1,941,511 Jun 23, 2021, 08:33 AM
Muralidhar Bali Director Jun 21, 2021 Buy $9.03 32,659 294,927 1,926,896 Jun 23, 2021, 08:33 AM
Muralidhar Bali Director Jun 08, 2021 Buy $9.50 16,605 157,709 1,894,237 Jun 10, 2021, 09:00 AM
Muralidhar Bali Director Jun 04, 2021 Buy $9.42 257 2,422 1,877,632 Jun 07, 2021, 08:53 AM
Muralidhar Bali Director Jun 03, 2021 Buy $9.25 12,100 111,943 1,877,375 Jun 07, 2021, 08:53 AM
Muralidhar Bali Director May 28, 2021 Buy $9.50 14 133 1,865,275 Jun 02, 2021, 10:37 AM
Muralidhar Bali Director May 26, 2021 Buy $9.38 5,915 55,495 1,864,141 May 28, 2021, 04:10 PM
Muralidhar Bali Director May 27, 2021 Buy $9.26 1,120 10,369 1,865,261 May 28, 2021, 04:10 PM
New Enterprise Associates 15, L.P. 10% Owner Apr 13, 2021 Buy $15.00 666,666 9,999,990 4,785,494 Apr 15, 2021, 06:16 PM
O'Donnell Niall Director Apr 13, 2021 Buy $15.00 200,000 3,000,000 2,063,713 Apr 15, 2021, 04:16 PM
Muralidhar Bali Director Apr 13, 2021 Buy $15.00 200,000 3,000,000 1,858,226 Apr 15, 2021, 04:15 PM
Novo Holdings A/S 10% Owner Apr 13, 2021 Buy $15.00 666,666 9,999,990 3,430,377 Apr 14, 2021, 04:44 PM
RiverVest Venture Fund III, L.P. 10% Owner Apr 09, 2021 Buy $15.00 200,000 3,000,000 2,409,220 Apr 13, 2021, 05:54 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Jindal Vineet R. Chief Financial Officer 08/25/2021 37,176
FLESHER GREGORY J. President and CEO 08/25/2021 64,000
Cruse Michael Senior VP-Corporate Operations 08/25/2021 18,616
Muralidhar Bali Director 07/14/2021 949,756
Johnson Wendy S. Chief Development Officer 07/14/2021 949,756
Johnson Wendy S. Chief Development Officer 07/08/2021 220,120
Muralidhar Bali Director 06/22/2021 127,487
Muralidhar Bali Director 06/21/2021 294,927
Muralidhar Bali Director 06/08/2021 157,709
Muralidhar Bali Director 06/04/2021 2,422
Muralidhar Bali Director 06/03/2021 111,943
Muralidhar Bali Director 05/28/2021 133
Muralidhar Bali Director 05/26/2021 55,495
Muralidhar Bali Director 05/27/2021 10,369
New Enterprise Associates 15, L.P. 10% Owner 04/13/2021 9,999,990
O'Donnell Niall Director 04/13/2021 3,000,000
Muralidhar Bali Director 04/13/2021 3,000,000
Novo Holdings A/S 10% Owner 04/13/2021 9,999,990
RiverVest Venture Fund III, L.P. 10% Owner 04/09/2021 3,000,000
Load More Insider Transactions